Effect of Medical Comorbidities on Procedural Success in Bronchoscopic Lung Volume Reduction
Open Access
- 14 January 2026
- journal article
- research article
- Published by MDPI AG in Journal of Respiration
- Vol. 6 (1) , 2
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and healthcare utilization. Lung volume reduction surgery improves outcomes in a select cohort but portends high morbidity. Bronchoscopic lung volume reduction (BLVR) is a less invasive, reversible manner of lung volume reduction, using one-way valves to improve lung function, quality of life, and exercise capacity. Nevertheless, knowledge gaps persist regarding factors that predict procedural success. Methods: We retrospectively reviewed 142 patients who underwent BLVR at the University of Chicago between December 2018 and July 2024 to assess the relationship between comorbidities and procedural outcomes. Using logistic and multinomial regression, we determined odds ratios (ORs) for a binary outcome of success and failure and relative risk ratios (RRRs) for failure sub-categories relative to procedural success. Results: We observed a procedural success rate of 48.1% and pneumothorax prevalence of 21.8%. After adjusting for age, sex, race, and body mass index (BMI), comorbidities associated with procedural failure included chronic kidney disease (CKD), congestive heart failure (CHF), anemia, and a BMI, Obstruction, Dyspnea and Exercise (BODE) Index of 5 or greater. Obstructive sleep apnea (OSA) was associated with procedural success. Conclusions: Comorbidities associated with dyspnea appear to have a significant effect on procedural success in BLVR.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy and Safety of Bronchoscopic Lung Volume Reduction With Endobronchial Valves: A Systematic Review and Meta-analysisOpen Respiratory Archives, 2025
- The multinomial logistic regression model for predicting the discharge status after liver transplantation: estimation and diagnostics analysisJournal of Applied Statistics, 2019
- A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)American Journal of Respiratory and Critical Care Medicine, 2018
- Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trialsBMJ Open Respiratory Research, 2018
- A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)American Journal of Respiratory and Critical Care Medicine, 2017
- COPD-OSA Overlap SyndromeChest, 2017
- Endobronchial Valve Therapy in Patients with Homogeneous Emphysema: Results from the IMPACT StudyAmerican Journal of Respiratory and Critical Care Medicine, 2016
- A Randomized Study of Endobronchial Valves for Advanced EmphysemaNew England Journal of Medicine, 2010
- Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: The Overlap SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2010
- St. George's Respiratory Questionnaire: MCIDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2005